Diana J. Azzam
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Oncology top 5%
- Cancer Cells and Metastasis 5
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 3
- PI3K/AKT/mTOR signaling in cancer 2
- Immunology top 10%
- Immunology and Allergy top 10%
-
- Neuroscience and Neuropharmacology Research 5
-
- Ovarian cancer diagnosis and treatment 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Joyce M. SlingerlandAndy J. MinnYu QiuBarzin Y. NabetMirjam C. BoelensPetra J. ter BruggeJos JonkersTaewon Yoon
- Partner nations
- United StatesLebanonPanama
In The Last Decade
Diana J. Azzam
23 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 618
- Oncology 549
- Molecular Biology 1.1k
- Immunology 236
- Immunology and Allergy 45
Countries citing papers authored by Diana J. Azzam
This map shows the geographic impact of Diana J. Azzam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana J. Azzam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana J. Azzam more than expected).
Fields of papers citing papers by Diana J. Azzam
This network shows the impact of papers produced by Diana J. Azzam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana J. Azzam. The network helps show where Diana J. Azzam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Diana J. Azzam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2022 | 48 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 64 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 25 | |
| 9 | 2019 | 12 | |
| 10 | 2018 | 57 | |
| 11 | 2016 | 26 | |
| 12 | 2016 | 143 | |
| 13 | 2014 | 31 | |
| 14 | 2014 | 219 | |
| 15 | Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathwaysbreakdown → | 2014 | 660 |
| 16 | 2012 | 54 | |
| 17 | 2011 | 12 | |
| 18 | 2010 | 48 | |
| 19 | 2008 | 11 | |
| 20 | 2007 | 1 |
About Diana J. Azzam
Diana J. Azzam is a scholar working on Cancer Research, Oncology and Neurology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Cancer Cells and Metastasis (5 papers), Epigenetics and DNA Methylation (3 papers), Ovarian cancer diagnosis and treatment (3 papers), MicroRNA in disease regulation (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Cancer Mechanisms and Therapy (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Cancer Research (618 citations), Oncology (549 citations) and Molecular Biology (1.1k citations). Diana J. Azzam has collaborated with scholars based in United States, Lebanon and Panama. Frequent co-authors include Joyce M. Slingerland, Andy J. Minn, Yu Qiu, Barzin Y. Nabet, Mirjam C. Boelens, Petra J. ter Brugge, Jos Jonkers, Taewon Yoon, Hemant Ishwaran and Bihui Xu. Their work appears in journals such as Cell, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.